Product Information

TOPAMAX 25 MG SPRINKLE CAP is a brand product labeled by Janssen Pharmaceuticals Inc., priced at $7.5693 per EA under NDC 50458064565. Its NADAC has been published 496 times since Nov 28, 2013.

FDA first approved this application on Oct 26, 1998. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TOPAMAX 25 MG SPRINKLE CAP

topiramate
$7.5693per EA

Strength

25 mg/1

NDC

50458064565

Classification

Brand

Dosage Form

CAPSULE, COATED PELLETS

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

TOPIRAMATE

Approval Type

New Drug (NDA)

FDA Application

NDA020844

FDA Approved

10/26/1998

TE Code

AB

On Market Since

11/1/1998

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for TOPAMAX 25 MG SPRINKLE CAP has been published 496 times since Nov 28, 2013, and over the history we have for it it has risen 86.4%. The table below summarizes its recorded NADAC range and movement.

Current price$7.5693 per EA
All-time high$7.5693 (Aug 19, 2026)
All-time low$4.0609 (Nov 28, 2013)
52-week high$7.5693
52-week low$7.3249
Median price$6.3310
Average price$6.1314
Largest weekly change+9.9% (Jan 15, 2014)
Weeks tracked496
Tracking sinceNov 28, 2013

Price History

1W

+0.3%

1M

+0.3%

3M

+0.3%

6M

+0.3%

1Y

+3.2%

3Y

+12.4%

5Y

+12.4%

All

+86.4%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 69% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TOPAMAX 25 MG SPRINKLE CAP?

The current National Average Drug Acquisition Cost (NADAC) for TOPAMAX 25 MG SPRINKLE CAP, manufactured by Janssen Pharmaceuticals Inc., is $7.5693 per EA (NDC 50458064565), effective Aug 19, 2026.

How has the price of TOPAMAX 25 MG SPRINKLE CAP changed over time?

Over the history we have for it, the NADAC for TOPAMAX 25 MG SPRINKLE CAP has risen 86.4%. It has been tracked across 496 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for TOPAMAX 25 MG SPRINKLE CAP?

Since Nov 28, 2013, the NADAC for TOPAMAX 25 MG SPRINKLE CAP has ranged from a low of $4.0609 (Nov 28, 2013) to a high of $7.5693 (Aug 19, 2026), with a median of $6.3310 per EA.

Are there cheaper alternatives to TOPAMAX 25 MG SPRINKLE CAP?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TOPIRAMATE ER 25 MG SPRINKL CAP, is $2.3344 per EA — about 69% below TOPAMAX 25 MG SPRINKLE CAP.

Who manufactures TOPAMAX 25 MG SPRINKLE CAP?

TOPAMAX 25 MG SPRINKLE CAP (NDC 50458064565) is labeled by Janssen Pharmaceuticals Inc., and CMS classifies it as a brand product.